Type I | Immune reaction to synthetic chemicals.
Those affected benefit greatly in the absence of synthetic chemical/vapor. Symptoms easily correlated to synthetic exposure and absence. Primary pathology is through inhalation causing direct CNS damage and not induced by neurotoxic bacteria.
Requires no other comorbid illness and is medically indeterminably at this time.
Also known as Functional Somatic Syndrome (FSS). See
Type II | Sensitivities driven by Neurotoxic Bacteria such as those found with mold, lyme, and other autoimmune gut-flora driven disorders and is medically determinable.
Symptoms are similar to Type I, but unlikely to improve in the absence of synthetic chemicals. A weak immune can be attributed to a diet lacking in nutrients necessary for good microbial gut-flora or an indoor environment with poor ventilation, low oxygen likely displaced by VOC’s. All contribute.
Autoimmunes are born of a weak immune.
Most neurotoxic bacterial infections become neurodegenerative with progression and will likely require treatments that include may include antibiotics, diet and appropriate probiotics. Characterized as ‘Brain on Fire’ and some as ‘Universal Reactors’. Sensitivities fluctuate with infection level and include smell reaction to both organic and synthetic odors.
EMF sensitivity have a comorbid autoimmune, as emf’s have been shown to inhibit ‘good’ microbial growth as well as prey on a weak immune.
Residual panic/anxiety disorders are more common to the severe Type II and historically addressed by either psychotropic medication, electro-convulsive therapy or DNRS.
Type III | Those induced by Mycotoxin inhalation poisoning causing holes in the BBB (blood brain barrier) thus leaving the CNS vulnerable to both organic and synthetic neurotoxins and not induced by poor gut-flora. Studies indicate the BBB can repair itself in the absence of triggering mycotoxins.
There is no one size fits all MCS and that is why it’s important to know what your treating when seeking help, and I am not a Doctor.